Regadenoson
- Product NDC
- 60505-6288
- 11-digit product format
- 605056288
- Labeler code
- 60505
- Product ID
- 60505-6288_a21106e5-4b14-7a34-523c-eb93b424d43d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- regadenoson
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Apotex Corp.
- Application
- ANDA207604
- Marketing category
- ANDA
- Marketing start
- 2025-04-03
- Substance
- REGADENOSON
- Active strength
- .08 mg/mL
- Pharmacologic classes
- Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 2XLN4Y044H | REGADENOSON | 875148-45-1 | REGADENOSON |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 60505-6288-0 | 60505628800 | 1 SYRINGE, PLASTIC in 1 CARTON (60505-6288-0) / 5 mL in 1 SYRINGE, PLASTIC | 2025-04-03 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Regadenoson | Apotex Corp. | Apotex Inc. | 2025-04-03 | HUMAN PRESCRIPTION DRUG LABEL | 2 |